Resultado de búsqueda
Hace 2 días · TG Therapeutics is a fully integrated, commercial stage, biopharmaceutical company focused on the acquisition, development and commercialization of novel treatments for B-cell diseases. In addition to a research pipeline including several investigational medicines, TG has received U.S. Food and Drug Administration (FDA) approval for BRIUMVI ...
2 de may. de 2024 · TG Therapeutics Inc (NASDAQ:TGTX) reported strong first-quarter financial results with total revenues exceeding $63 million, driven by robust sales of BRIUMVI in the U.S. which amounted to over...
Hace 3 días · Get a real-time TG Therapeutics, Inc. (TGTX) stock price quote with breaking news, financials, statistics, charts and more.
- 2.15B
- 233.66M
- 12.67M
- 154.54M
16 de may. de 2024 · Stock analysis for TG Therapeutics Inc (TGTX:NASDAQ CM) including stock price, stock chart, company news, key statistics, fundamentals and company profile.
- 264
1 de may. de 2024 · NEW YORK, May 01, 2024 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX) (the Company or TG Therapeutics) today announced its financial results for the first quarter of 2024, along with ...
- TG Therapeutics, Inc.
1 de may. de 2024 · TG Therapeutics ( NASDAQ: TGTX) shares rose ~26% in the premarket on Wednesday after the biotech exceeded expectations with its Q1 2024 revenue, as U.S. sales from its multiple sclerosis therapy ...
17 de may. de 2024 · See the latest TG Therapeutics Inc stock price (TGTX:XNAS), related news, valuation, dividends and more to help you make your investing decisions.
